Massive korean study tests diabetes drug for heart attack recovery
NCT ID NCT07198191
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study looks at whether a common diabetes medicine called SGLT2 inhibitor can help people with type 2 diabetes who have had a heart attack. Researchers will compare health records of 200,000 people in Korea who took either an SGLT2 inhibitor or another diabetes drug after their heart attack. The goal is to see if the SGLT2 group has fewer heart problems or deaths. This is an observational study, meaning researchers are just looking at past data, not giving any new treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yongin Severance Hospital, Yonsei University Health System
Yongin, Gyeonggi-do, 16995, South Korea
Conditions
Explore the condition pages connected to this study.